{
  "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2",
  "docSlug": "9cc11288f450409d9a3eef75fc694943",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 39,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a Venn diagram to illustrate the intersection of two key clinical challenges.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/6",
  "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2",
  "deckJsonHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2.json",
  "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.8,
        "w": 0.45,
        "x": 0.5,
        "y": 0.1
      },
      "kind": "diagram",
      "text": "Kinase Resistance and Kinase Selectivity intersection",
      "attrs": null,
      "subkind": "venn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef05cc47-a644-4c82-bb8e-83fd49807dbd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.42,
        "x": 0.07,
        "y": 0.55
      },
      "kind": "list",
      "text": "Expertise in structure-based drug design to create innovative small molecules\n“Threading the needle”: Aim to achieve high affinity for drug-resistant kinases while avoiding off-target kinases in the central nervous system (CNS) and in the periphery\nPotential to minimize adverse events AND drive more durable responses",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80084627-bac9-434e-b79b-6be8b9b3c63a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.42,
        "x": 0.07,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "Nuvalent is focused on creating precisely targeted therapies to overcome key limitations of existing therapies for clinically proven kinases and renew hope for patients in need",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d53d8870-4ae2-4a31-8268-2f9abd1d5cda",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.38,
        "x": 0.07,
        "y": 0.12
      },
      "kind": "title",
      "text": "PRECISELY Targeted Therapies for patients with cancer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33bec626-bb08-43e0-ba55-bced8e79f935",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Venn diagram",
      "slug": "venn-diagram",
      "agent": null,
      "layer": "slide",
      "matchId": "2fd327d1-6038-4d2c-803c-4f0729f6c018",
      "evidence": "diagram/venn: Kinase Resistance and Kinase Selectivity intersection",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "venn",
      "slug": null,
      "matchId": "51fc2832-f339-4139-9c15-7e6dd910b290",
      "evidence": "Overlapping circles representing the intersection of two clinical goals",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 6,
      "beatId": "096363d4-975e-4e25-a560-737614c6b572",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The document presents Nuvalent's solution, precisely targeted therapies, as a potential answer to the problem.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}